FDA approves Merck’s RSV antibody drug for babies

The FDA approved Merck’s RSV antibody for babies, teeing up a rivalry with Sanofi and AstraZeneca’s Beyfortus. The decision adds a new entrant to the RSV prevention space for the youngest kids, and makes a …